Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2000-2-4
pubmed:abstractText
Ischemia/reperfusion injury leads to delayed graft function, which is a major problem in kidney transplantation. This study investigated the effects of adding trimetazidine (TMZ) to the perfusate of cold-stored kidneys on the function of reperfused autotransplanted pig kidney. The left kidney was removed and cold-flushed with Euro-Collins (EC), or University of Wisconsin (UW) solutions with or without 10(-6)M TMZ and stored for 48 h at 4 degrees C. The kidneys were then autotransplanted and the contralateral kidneys were removed. Several parameters were analyzed over the 14 d after transplantation. The survival rate was 57% in pigs transplanted with kidneys cold-flushed with UW and 43% for those flushed with EC solution; it was 100% for pigs having kidneys cold-flushed with TMZ-supplemented UW and EC solutions. The functions of the transplanted kidneys were also better preserved after cold flush with TMZ-supplemented solutions than with TMZ-free solutions. Creatinine clearance was higher and the urinary excretion of trimethylamine-N-oxide and dimethylamine, used as markers of renal medulla injury, were lower in animals transplanted with kidneys cold-flushed with TMZ-supplemented solutions than with TMZ-free solutions. The cytoprotective action of TMZ also reduced interstitial and peritubular inflammation and the numbers of infiltrating mononuclear CD45+and CD3+ T cells. These results indicate that the tissue damage due to ischemia/reperfusion injury may be prevented, at least in part, by adding TMZ to preservation solutions.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
1046-6673
pubmed:author
pubmed:issnType
Print
pubmed:volume
11
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
138-48
pubmed:dateRevised
2008-11-21
pubmed:meshHeading
pubmed-meshheading:10616850-Animals, pubmed-meshheading:10616850-Cold Temperature, pubmed-meshheading:10616850-Dimethylamines, pubmed-meshheading:10616850-Disease Models, Animal, pubmed-meshheading:10616850-Graft Rejection, pubmed-meshheading:10616850-Graft Survival, pubmed-meshheading:10616850-Kidney, pubmed-meshheading:10616850-Kidney Function Tests, pubmed-meshheading:10616850-Kidney Transplantation, pubmed-meshheading:10616850-Male, pubmed-meshheading:10616850-Methylamines, pubmed-meshheading:10616850-Reference Values, pubmed-meshheading:10616850-Reperfusion Injury, pubmed-meshheading:10616850-Swine, pubmed-meshheading:10616850-Transplantation, Autologous, pubmed-meshheading:10616850-Treatment Outcome, pubmed-meshheading:10616850-Trimetazidine, pubmed-meshheading:10616850-Vasodilator Agents
pubmed:year
2000
pubmed:articleTitle
Trimetazidine reduces renal dysfunction by limiting the cold ischemia/reperfusion injury in autotransplanted pig kidneys.
pubmed:affiliation
Unité de Chirurgie Expérimentale, Départment de génétique animale, Institut National de la Recherche Agronomique, Le Magneraud, Surgères, France. hauet@magneraud.inra.fr
pubmed:publicationType
Journal Article, Comparative Study, Research Support, Non-U.S. Gov't